We are live on ! Find out more
KPF

K2 Principal Fund Portfolio holdings

AUM $1.43B
1-Year Est. Return 29.56%
This Fund
S&P 500
This Quarter Est. Return
-8.03%
1 Year Est. Return
+29.56%
3 Year Est. Return
+71.66%
5 Year Est. Return
+57.43%
10 Year Est. Return
+278.66%
AUM
$1.16B
AUM Growth
-$351M
Cap. Flow
-$335M
Cap. Flow %
-28.92%
Top 10 Hldgs %
45.37%
Holding
494
New
126
Increased
47
Reduced
55
Closed
192

Top Buys

Rank Stock Value
1
PFSI icon
PennyMac Financial
PFSI
+$32M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$29.2M
3
NMRK icon
Newmark Group
NMRK
+$11.5M
4
COIN icon
Coinbase
COIN
+$9.28M
5
BMO icon
Bank of Montreal
BMO
+$8.82M

Top Sells

Rank Stock Value
1
SKIN icon
SkinHealth Systems
SKIN
+$24.3M
2
BG icon
Bunge Global
BG
+$15.9M
3
CIXX
CI Financial Corp.
CIXX
+$12.4M
4
TRIS
Tristar Acquisition I Corp.
TRIS
+$11.2M
5
SAGAU
Sagaliam Acquisition Corp. Units
SAGAU
+$9.93M

Sector Composition

Rank Sector Weight
1 Financials 16.69%
2 Real Estate 2.6%
3 Technology 2.09%
4 Communication Services 1.94%
5 Consumer Staples 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBSC.WS
251
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$46K ﹤0.01%
184,626
+134,626
+269% +$52.5K
CLRMW
252
DELISTED
Clarim Acquisition Corp. Warrant
CLRMW
$45K ﹤0.01%
193,018
– –
IMAQR
253
DELISTED
International Media Acquisition Corp. Rights
IMAQR
$44K ﹤0.01%
400,000
– –
MPACR
254
DELISTED
Model Performance Acquisition Corp. Right
MPACR
$44K ﹤0.01%
244,800
-10,000
-4% -$2.71K
ENERW
255
DELISTED
Accretion Acquisition Corp Warrant
ENERW
$43K ﹤0.01%
250,000
– –
CCVI.WS
256
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$43K ﹤0.01%
+79,155
New +$59.8K
HORIW
257
DELISTED
Emerging Markets Horizon Corp. Warrants
HORIW
$43K ﹤0.01%
+310,000
New +$73.1K
COVAW
258
DELISTED
COVA Acquisition Corp. Warrants to purchase Class A ordinary shares
COVAW
$38K ﹤0.01%
210,523
-234,959
-53% -$78.9K
NVACW
259
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$37K ﹤0.01%
+197,000
New +$34.9K
JAQCW
260
DELISTED
Jupiter Acquisition Corporation Warrants
JAQCW
$37K ﹤0.01%
113,474
-289,026
-72% -$100K
RMCOW icon
261
Royalty Management Holding Warrant
RMCOW
$1.39M
$36K ﹤0.01%
238,000
– –
NOVVR
262
DELISTED
Nova Vision Acquisition Corp. Rights
NOVVR
$36K ﹤0.01%
270,000
– –
BWAQW
263
DELISTED
Blue World Acquisition Corporation Warrant
BWAQW
$33K ﹤0.01%
+300,000
New +$36.8K
ESLAW icon
264
Estrella Immunopharma Warrant
ESLAW
$210K
$32K ﹤0.01%
143,947
– –
DSAQ.WS
265
DELISTED
Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DSAQ.WS
$31K ﹤0.01%
125,000
– –
FTPAW
266
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
$30K ﹤0.01%
81,028
-87
-0.1% -$50
OCEAW
267
DELISTED
Ocean Biomediacal, Inc. Warrants
OCEAW
$28K ﹤0.01%
125,000
– –
IQMDW
268
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
$27K ﹤0.01%
98,684
-1,316
-1% -$480
SANBW
269
DELISTED
Sanaby Health Acquisition Corp. I Warrant
SANBW
$27K ﹤0.01%
125,000
– –
ROSEW
270
DELISTED
Rose Hill Acquisition Corporation Warrant
ROSEW
$26K ﹤0.01%
100,000
– –
MLAIW
271
DELISTED
McLaren Technology Acquisition Corp. Warrant
MLAIW
$25K ﹤0.01%
125,000
– –
NFNT.WS
272
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$23K ﹤0.01%
+76,442
New +$33.4K
NOVVW
273
DELISTED
Nova Vision Acquisition Corp. Warrant
NOVVW
$23K ﹤0.01%
270,000
– –
HMA.WS
274
DELISTED
Heartland Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
HMA.WS
$19K ﹤0.01%
+117,098
New +$19.5K
ALACR
275
DELISTED
Alberton Acquisition Corp Rights
ALACR
$19K ﹤0.01%
66,488
-249,587
-79% -$82.5K
9 10
11
12 13

Similar funds

KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return
LCG
Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return
CCM
Callodine Capital Management Boston, Massachusetts $1.43B AUM 8.74% 1-Year Est. Return
TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return

K2 Principal Fund's Q1 2022 Portfolio in Review

As of Q1 2022, K2 Principal Fund held 494 positions worth $1.16B, down 23% from $1.51B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

K2 Principal Fund withdrew a net $335M in Q1 2022, closing 192 positions and reducing 55 holdings. Its most notable exit was Bunge Global, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Real Estate and Technology.

Against the trend, K2 Principal Fund opened a new position in State Street SPDR S&P 500 ETF Trust worth $29.6M.

  • K2 Principal Fund's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 65,553 shares worth $29.6M.
  • K2 Principal Fund added most to PennyMac Financial in Q1 2022, an estimated $32M increase.
  • K2 Principal Fund's biggest Q1 2022 reduction was SkinHealth Systems, cutting an estimated $24.3M.
  • K2 Principal Fund fully exited Bunge Global in Q1 2022, selling an estimated $15.9M.
  • K2 Principal Fund's ten largest holdings make up 45% of its $1.16B portfolio in Q1 2022.
  • K2 Principal Fund opened 126 new positions and closed 192 in Q1 2022.
  • K2 Principal Fund's portfolio value fell 23% quarter-over-quarter to $1.16B.

Based on K2 Principal Fund's 13F filing for Q1 2022, filed 16 May 2022.